Fuzheng Huazhuo formula in the treatment of asymptomatic and mild COVID-19: a retrospective cohort study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200064846

Enrollment

Unknown

Registered

2022-10-19

Start date

2022-10-18

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

exposure group:Basic treatment+Fuzheng Huazhuo formula

non-exposed group:Basic treatment

Eligibility

Sex/Gender

All

Age

1 Years to 99 Years

Inclusion criteria

Inclusion criteria: Asymptomatic infections and mild confirmed cases of the new coronavirus by etiological testing.

Exclusion criteria

Exclusion criteria: 1. Patients with serious primary diseases of heart, brain, liver, kidney and hematopoietic system; 2. Allergic to prescribed drugs.

Design outcomes

Primary

Measure	Time frame
negative time of nucleic acid test;	—

Secondary

Measure	Time frame
negative rate of nucleic acid test;nucleic acid cycle threshold value;hospital duration;	—

Countries

China

Contacts

Public ContactWu Hongze

Jiujiang Hospital of Traditional Chinese Medicine

whzzyy@163.com+86 18970256865

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026